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ABSTRACT Deregulated cardiomyocyte death is a critical risk factor in a variety of cardiovascular diseases. Although various
assays have been developed to detect cell responses during cell death, the capability of monitoring cell detachment will enhance
the understanding of death processes by providing instant information at its early phase. In this work, we developed an imped-
ance-sensing assay for real-time monitoring of cardiomyocyte death induced by tumor necrosis factor-a based on recording the
change in cardiomyocyte adhesion to extracellular matrix. Electrochemical impedance spectroscopy was employed in imped-
ance data processing, followed by calibration with the electrical cell-substrate impedance-sensing technique. The adhesion
proﬁle of cardiomyocytes undergoing cell death processes was recorded as the time course of equivalent cell-substrate distance.
The cell detachment was detected with our assay and proved related to cell death in the following experiments, indicating its
advantage against the conventional assays, such as Trypan blue exclusion. An optimal concentration of tumor necrosis
factor-a (20 ng/mL) was determined to induce cardiomyocyte apoptosis rather than the combinative cell death of necrosis
and apoptosis by comparing the concentration-related adhesion proﬁles. The cardiomyocytes undergoing apoptosis experi-
enced an increase of cell-substrate distance from 59.1 to 89.2 nm within 24 h. The early change of cell adhesion was proved
related to cardiomyocyte apoptosis in the following TUNEL test at t ¼ 24 h, which suggested the possibility of early and nonin-
vasive detection of cardiomyocyte apoptosis.
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Cardiomyocyte loss by cell death is significantly dangerous
because it causes irreversible damage to adult hearts because
of their very limited regeneration capability. It was reported
in a recent publication that cell death, whether by apoptosis
or necrosis, can lead to heart failure (1). Currently, in the
in vitro study of cardiomyocyte cell death, the most common
assays for cell viability are microscopic examination of
chemically stained cells. Despite great advances that have
been made with these approaches, additional research has
been conducted to develop noninvasive techniques for real-
time monitoring of cell death. In both necrotic and apoptotic
cell death processes, it is a common phenomenon that cells
detach from the extracellular matrix (ECM). Especially,
cell detachment occurs at the early phase of cell death, which
suggests the possibility of detecting ongoing cell death
processes by monitoring cell adhesion.
It has long been recognized that electric cell-substrate
impedance sensing (ECIS) is a noninvasive and sensitive
detecting technique for cell adhesion (2,3). In the last two
decades, ECIS sensing has been employed to monitor
many types of cells, including fibroblasts, endothelial cells,
and cancer cells (4–11). More recently, ECIS research has
turned to excitable cells, such as skeletal muscle cells (12)
and cardiomyocytes (13,14). Generally, time courses of
overall impedance during the biological processes were
recorded in time intervals and attributed to various cell
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the overall signals, researchers (15,16) further developed
advanced data-processing techniques. In these methods,
paracellular current flow in the medium gap between cells
and electrodes is described in the infinite element model
(15,17) where the cell body is assumed to exhibit known
and stable capacitance. It has been reported that this
advanced ECIS method is capable of detecting vertical
motion on the order of 1 nm (3). Combined with other
biophysical and biochemical assays, advanced ECIS has
been applied to study apoptosis of endothelial cells (18).
However, unlike endothelial cells or fibroblasts in the
reported ECIS studies that exhibit known and constant elec-
trical properties because of reliable commercialized cell
lines, cardiomyocytes are primarily cultured, which means
electrical properties of cardiomyocytes needed in the ECIS
calculation are unknown and unstable. This is essentially
the bottleneck of ECIS application to cardiomyocyte
research. In our previous work (19), impedance spectra ob-
tained in cyclic frequency scanning were used to determine
the unknown membrane capacitance of cardiomyocytes
based on electrochemical impedance spectroscopy (EIS).
A methodology was established on the basis of ECIS and
EIS to calculate the equivalent cell-substrate distance, which
mader it possible to carry out real-time monitoring of
ongoing biological processes in cardiomyocytes and other
primary cells.
In this work, the ongoing cardiomyocyte cell death
induced by tumor necrosis factor-a (TNF-a) was real-time
monitored and recorded in time courses of equivalent
doi: 10.1016/j.bpj.2008.11.036
cell-substrate distance calculated by our methodology. Cell
adhesion profiles were recorded at multiple TNF-a concen-
tration levels, and the results were compared with those of
TBE tests. The comparison showed that our assays picked
up cell detachment in advance of obvious difference seen
in Trypan blue exclusion (TBE) tests. Furthermore, the
distinct cell adhesion profiles indicated that different cell
death mechanisms were experienced at different concentra-
tion levels. Namely, apoptosis could be the main death
mechanism in cardiomyocytes treated with 20 ng/mL
TNF-a. Its slowly detaching profile was proven related to
cardiomyocyte apoptosis in the following terminal uridine
deoxynucleotidyl transferase dUTP nick-end labeling
(TUNEL) test.
EXPERIMENTAL SECTION
Fabrication
The fabrication of the biosensing chips was conducted in a microfabrication
laboratory. A glass slide was chosen as the substrate material because it
could minimize the substrate capacitance and decrease the measurement
noise. The electrode voids of the chips were patterned on the slides with
photoresist Shipley 1813 in photolithography on the MA6 aligner. Effective
adhesion of the metal electrodes to the glass substrate was required; there-
fore, a chromium layer (125 A˚) was first deposited by thermal evaporation,
followed by the deposition of the major electrode components with gold
(375 A˚) (Kurt J. Lesker , Pittsburgh, PA). The metal electrodes were defined
in a lift-off process. SiO2 and SiNx (Kurt J. Lesker Co.) were deposited with
magnetic sputtering to form an insulating layer with a thickness of 1200 A˚.
Windows were defined in the insulating layer using photolithography and
opened by reactive ion etching to access the gold electrode surface. A bio-
sensing chip consisted of 16 circular working electrodes (0.502 mm2) and
one common rectangular counterelectrode (2.0 cm2). Fig. 1 a shows the
configuration of the biosensing chip.
Testing systems
The schematic diagram and photo of our impedance-sensing system is de-
picted in Fig. 1 b. The biosensing chip was maintained in the incubator at
5% CO2 and 37
C throughout the electrical measurement to avoid any fluc-
tuations in the testing environment. Inside the incubator, the biosensing chip
was mounted to a homemade silicone chamber designed for cell culture. The
electrode pads were connected to micromanipulators, which transferred
signals through an Agilent 16048A BNC test fixture to the outside of the
chamber. The impedance of the electrodes in the chip was measured with
an Agilent 4284A LCR meter (Agilent Technologies, Santa Clara, CA).
For automatic measurement and data logging, the LCR meter was connected
to a computer through a GPIB interface. The impedance measurement
process was controlled by LabView (National Instruments Corp., Austin,
TX) virtual instruments.
Cardiomyocyte isolation and culture
Left ventricular myocytes were isolated from male Wistar rats according to
a previously established protocol with some modifications (20). The rat
heart was separated and perfused with Ca2þ-free Krebs buffer (0.12 M
NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 M NaHCO3,
and 12 mM glucose) and enzyme buffer (375 mg/L collagenase and
425 mg/L hyaluronidase in Ca2þ-free Krebs buffer). The rat heart was
then cut into 8 to 10 small pieces and dispersed in enzyme buffer (trypsin
0.3 mg/mL and DNAase 0.3 mg/mL in Ca2þ-free Krebs buffer). The cardi-
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resulting in a typical yield of >90% rod-shaped cells. The isolated cells
were then washed with Dulbecco’s Modified Eagle Medium and were ready
for plating onto microelectrodes. For the ECM, a laminin suspension was
prepared by diluting the laminin solution (Becton-Dickinson, Franklin
Lakes, NJ) in serum-free medium at volume ratio of 1:100. The laminin
suspension was dropped onto the impedance-sensing electrodes, which
were then kept still in the incubator for at least 30 min until a laminin layer
formed. For electrical measurement, the biosensing chip was inoculated
with 1.5 mL of the cardiomyocyte suspension, leading to a concentration
of 5  104 cells/cm2 of electrode area.
Frequency scanning and impedance
spectroscopy
The measurement of impedance was performed with 80 frequencies loga-
rithmically spaced between 20 Hz and 200 kHz with a 5-mV voltage exci-
tation. One round of frequency scanning was completed in 1 min. For
continuous monitoring, cyclic frequency scanning was applied to the testing
system every 10 min. The impedance data were recorded as real and imag-
inary components accompanied by the testing frequency in a.txt file, which
was convenient for the following data processing and analysis.
Despite the existing curve-fitting software, for example, LEVM,
a complex nonlinear least-square (CNLS) curve fitting program was written
based on the optimizing toolbox of MATLAB. This provided a convenient
approach to process the impedance data obtained through the LabView
virtual instrument and to carry out the following calculations and plotting.
FIGURE 1 (a) Top view and close view of the counter and testing elec-
trodes fabricated in a lift-off process (Cr/Au: 125 A˚/375 A˚). Chromium
was used to increase the adhesion of the gold layer to the glass substrate.
A laminin (an ECM protein) layer was coated before cardiomyocytes
were injected. (b) Schematic diagram of the impedance measurement
system. The part surrounded by dashed lines is inside the incubator
(37C, 5% CO2).
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TNF-a treatment and evaluation of cell viability
and apoptosis
TNF-a (Sigma-Aldrich, St. Louis, MO) treatment was carried out in serum-
free medium after 24-h culture for stabilization. Cardiomyocytes were incu-
bated with different concentrations of TNF-a for 24 h. Cyclic frequency
scanning was applied to the samples as soon as the TNF-a treatment began.
Evaluation of cell viability was conducted with TBE test in which 0.4%
Trypan blue solution (Sigma-Aldrich) was used. The applied concentration
of Trypan blue was 5% v/v. The samples were analyzed on a fluorescent
microscope (Nikon Eclipse TS100-F; Nikon Instruments, Melville, N.Y.).
More than 700 cells were counted in 10 fields for each independent exper-
iment.
Apoptosis was detected with the TUNEL test in which the In Situ Cell
Death Detection Kit, Fluorescein (Roche Applied Science, Indianapolis,
IN) was used. After the treatment with TNF-a, cardiomyocytes were washed
three times in phosphate-buffered saline (PBS) and then fixed with 4% para-
formaldehyde in PBS for 1 h at room temperature. Cardiomyocytes were then
permeabilized for 2 min on ice with 0.1% Triton X-100 in 0.1% sodium
citrate. After two rinses with PBS, 50 mL TUNEL reaction mixtures were
added on the cardiomyocytes, followed by incubation for 1 h in a humidified
and dark chamber. Cardiomyocytes were rinsed three times with PBS and
strained with 4’,6-diamidino-2-phenylindole (DAPI). More than 500 cells
were counted in 10 fields for each independent experiment.
RESULTS AND DISCUSSION
Characterization of the impedance-sensing
system
In our experimental setup, cardiomyocytes were cultured on
the electrode covered by ECM protein, specifically laminin.
The impedance spectra were recorded before and after addi-
tion of freshly isolated cardiomyocytes into the suspension,
so that the characteristics of the cell-free and cell-covered
impedance-sensing system could be determined and
described with equivalent circuit models.
Impedance analysis of the cell-free system
The impedance-sensing system without cells (Zn) can be
represented by the equivalent circuit model shown in Fig. 2
a. Here, the dielectric characteristics of the protein layer (lam-
inin) are considered an ideal capacitor (Cp) on the electrode
surface. However, because laminin consists of macromole-
cules of ~900 kDa in molecular mass and ~10 nm in length
(21), it is difficult to achieve complete and compact coverage
of laminin over the electrode surface. Research does demon-
strate that pores exist among themacroproteinmolecules (22).
Solution can enter these poles and reach the gold electrode
surface (Fig. 2 b), which can induce nonideal capacitance
and resistance. Therefore, a constant-phase element (CPE)
is used to account for the nonlinearities of frequency-related
electrical double-layer impedance (ZCPE ¼ ½QCPEðjuÞn1,
where j and u are the imaginary unit and angular frequency,
respectively) on the naked gold surface (23,24). The resistor
Rp is used to represent the pore resistance in the laminin layer.
Both the current flows via protein molecules and via pores in
the protein coating layer travel in the bulk medium repre-
sented with a resistor (Rs
0).
Impedance Sensing of Cardiomyocyte DeathThe equivalent circuit model was fit to the three-dimen-
sional impedance response plot of the impedance-sensing
system, as shown in Fig. 3 a. To determine the element
parameters of the impedance-sensing system, the CNLS
curve fitting was performed to the equivalent circuit model
in Fig. 2 a. The P weighting (25) was added into the objec-
tive function of CNLS curve fitting to ensure the validity in
case the fitting to the real or imaginary component of
impedance was unbalanced. The element parameters were
determined for the cell-free impedance-sensing system:
Rs
0 ¼ 2.22 5 0.03 U cm2, Cp ¼ 5.46 5 0.13 mF/cm2,
Rp ¼ 2.255 0.23 U cm2, QCPE ¼ 124.92 5 0.33 mF/cm2,
n ¼ 0.8055 0.003.
Impedance analysis of the cell-covered system
Once the cell-free system had been characterized, themedium
containing laminin was drained and replaced with the cardio-
myocyte suspension. After the cells settled down on the
biosensing chip, the total impedance (Zc) could be considered
as the combination of cell-related impedance (Zr) and Zn with
the exception of Rs
0 (Zr ¼ Zc  ðZn  R0sÞ). We built the
cardiomyocyte layer model on an electrode based on EIS. In
our equivalent circuit model of Zr (Fig. 2 c), Cc is used to
represent the reactance of cells, and Rg is used to describe
the resistance of the thin medium layer in the cell-substrate
and cell-cell gap. Rs is the resistance of bulk medium body.
To achieve automation of the data processing, the admittance
response (Yr ¼ 1/Zr) in a Nyquist plot was first characterized
(19). The electrical parameters acquired in the Nyquist plots
FIGURE 2 (a) Equivalent circuit model of system impedance without
cells. Rs
0 is the resistance of bulk solution and the wire connection. The
capacitance of the laminin layer is represented by Cp. ZCPE and Rp are
used to describe nonideal capacitive response of the uncovered electrode
surface and the resistance in the pores of the laminin layer. (b) Current
flow patterns on the testing electrode. There are two modes of current in
the protein coating layer: one travels via solution in the pores among protein
molecules; the other travels via protein molecules. There are also two modes
of current in the cardiomyocyte layer: the paracellular mode represents how
the current travels in solution around cells; the transcellular mode represents
how the current travels through the cell body. (c) Equivalent circuit model of
impedance of the cell-covered electrode (Zc). The impedance response to
paracellular or transcellular current is described with resistors or capacitors,
respectively. Specifically, Rg is the resistance of the medium layer in the cell-
substrate and cell-cell gap. When cardiomyocytes begin to adhere to ECM
protein, the decrease in the cell-substrate gap will result in an increase in Rg.
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FIGURE 3 (a) Characterization of cell-free impedance
sensing system (Zn) with CNLS curve fitting with P
weighting in the objective function. The curve fitting was
performed with a program developed from the optimizing
function toolbox of MATLAB. According to the conven-
tion of the electrochemical society, Z ¼ ZRe  jZIm. (b)
CNLS curve fitting of the cell-related impedance to the
EIS model with P weighting in the objective function.
The related electrical parameters Rg, Rs, and Cc are deter-
mined.
1988 Qiu et al.of Yr were utilized as the iterative initial points of the
following CNLS curve fitting. As shown in Fig. 3 b, the
best fit of cell-related impedance spectra was obtained with
Rg ¼ 2.715 0.09 U m2, Cc ¼ 1.045 0.05 mF/cm2, and Rs
¼ 2.39 5 0.16 U cm2. Every loop in the cyclic frequency
scanning went through the EIS data processing to determine
Rg, Cc, and Rs values.
Specifically, because the cell-substrate and cell-cell gaps
change synchronously, the variation of Rg could be assumed
inversely proportional to that of normalized cell-substrate
distance because the Rg was present because of the resistivity
of the conductive solution, which obeyed the Ohm’s law
(19). The automatic recording of Rg could be translated
into a time course of normalized cell-substrate distance.
ECIS calibration of absolute cell-substrate
distance
The calibration of absolute cell-substrate distance was
performed with Lo’s cell model (16) and the cell-related
electrical parameter extracted above. Especially, the imped-
ance through the body of the cell was considered as the
capacitive reactance of cell membrane, which filled in the
gap of unknown electrical properties of primary cardiomyo-
cytes in ECIS calibration.
Lo’s cell model (16) was described as a flat rectangular
(L  W) box and a half-disk (rc ¼ W/2) on each end. In
this method, specific impedances of cell-covered (Zc) and
cell-free (Zn) electrodes were calculated by multiplying the
measured impedance by the electrode area. The impedance
through a cell body was expressed as the reactance of Cc
in the EIS model: Zm ¼ j=ðuCcÞ. The best fit of ECIS
(Fig. 4) was obtained with absolute cell-substrate distance
of 59.1 5 2.0 nm and junctional resistance among cells of
2.345 0.09 U m2.
Although the absolute cell-substrate distance could be
obtained through ECIS calibration, the absence of iterative
initial points restricted its application in processing isolated
data at a single moment. To achieve the continuous recording
of cell adhesion, the time course of equivalent cell-substrate
distance was defined as the product of the time course of
normalized cell-substrate distance and absolute value
obtained in ECIS calibration.
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The cell-substrate distance would be an ideal parameter to
quantify the extent of cell adhesion, which was highly related
to cell responses to various stimuli. Freshly isolated cardio-
myocytes were first cultured on the working electrodes for
24 h to achieve a stable adhesion to ECM. The equivalent
cell-substrate distance was then recorded for the cardiomyo-
cytes that were undergoing cell death. TBE and TUNEL
assays were employed to prove the occurrence of cell death
and apoptosis, respectively.
Concentration-related adhesion proﬁles
of cardiomyocyte death
Cardiomyocytes treated with different concentrations of
TNF-a exhibited distinct adhesion profiles, i.e., the
increasing rate and extent of equivalent cell-substrate
distance. Fig. 5 a showed the representative results of three
independent experiments in which five concentrations of
TNF-a were applied (0 to ~80 ng/mL). Although the initial
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FIGURE 4 ECIS calibration of absolute cell-substrate distance based on
Lo’s cell model (16).
a0 200 400 600 800 1000 1200 1400
60
80
100
120
140
160
180 TNF−α 80 ng/mL
TNF−α 40 ng/mL
Control
TNF−α 20 ng/mL
Eq
ui
va
le
nt
 d
ist
a
n
ce
 
(nm
)
Time (min)
TNF−α 10 ng/mL
b
0 20 40 60 80 100 120
0.9
1.0
1.1
1.2
1.3
1.4
1.5
1.6
 Control
 TNF-α 10 ng/mL
 TNF-α 20 ng/mL
 TNF-α 40 ng/mL
 TNF-α 80 ng/mL
N
or
m
a
liz
e
d 
ce
ll-
su
bs
tra
te
 d
is
ta
nc
e
Time (min)
c
0
10
20
30
40
50
60
TNF-α
80 ng/mL
TNF-α
40 ng/mLControl
TNF-α
20 ng/mL
TNF-α
10 ng/mL
Pe
rc
en
ta
ge
 
o
f T
BE
 p
os
iti
ve
 (%
)  t=0.5 h
 t=1 h
 t=24 h
FIGURE 5 (a) Adhesion profiles of cardiomyocytes
treated continuously with different concentrations of
TNF-a. (b) Adhesion profiles of treated cardiomyocytes
in the first 2 h. For comparison, equivalent cell-substrate
distances were normalized to their respective initial values.
(c) Percentage of death obtained with TBE tests in treated
cardiomyocytes at t ¼ 0.5 h, t ¼ 1 h, and t ¼ 24 h. Data
from three independent experiments are shown as
mean5 SD.
Impedance Sensing of Cardiomyocyte Death 1989equivalent distances were close, the five curves were distinct
from each other in the 24-h continuous recording. At the end
of treatment, the final distances varied from 61.3 nm to
176.7 nm, which were in an increasing order of TNF-a
concentration. The increase of cell-substrate distance was
a result of ongoing cell death, including apoptosis and
necrosis, in which cell detachment would occur no matter
which death mechanism was dominant. The diversity in
increasing amplitude could be caused by the different
percentages of cardiomyocytes ongoing cell death. It indi-
cated the concentration of TNF-a was an important experi-
mental factor in inducing cell death of cardiomyocytes.
Furthermore, the increasing rates of equivalent cell-substrate
distance were also strongly influenced by the TNF-a concen-
tration. The samples treated with higher concentrations
exhibited faster ascent than those with lower concentrations.
Especially at the beginning stage of treatment, the 10 and
20 ng/mL samples experienced a drop in equivalent distance
for ~2 h and then continued ascent at slow rates in the
following hours. On the contrary, the 40 and 80 ng/mL
samples began to detach from the ECM immediately after
addition of TNF-a (Fig. 5 b). The increasing rate of equiva-
lent distance was determined by the rate of cell death
percentage. Because the apoptotic process was much slower
than the necrotic process as a result of differences between
two mechanisms, necrosis could be predominant in the fast
rate of cell death percentage that was observed in the cardi-
omyocytes treated with higher concentrations of TNF-a.
The cell detachment observed in our assay was related to
the activation of the TNF-a-induced cardiomyocyte death
process. The TBE test was employed for the demonstration
of cell death. Before the TNF-a treatment, the death
percentage of cardiomyocytes was 3.3 5 0.7%. After30 min of treatment, even though no obvious difference
could be found in the TBE results (Fig. 5 c), cell detachment
was observed with our assay in the 40 and 80 ng/mL TNF-
a-treated samples. The rapid cell detachment was related
to the cell death in the following TBE tests at t¼ 1 h in which
the death percentages of samples treated with 40 and
80 ng/mL TNF-a were remarkably higher than those of other
samples. The early detection of cell detachment provided us
real-time information about ongoing cell death in cardio-
myocytes before the TBE tests. Furthermore, because it takes
at least 2 h to activate the caspase family for the execution of
TNF-a-induced apoptosis (26), the TBE-positive cardio-
myocytes observed at t ¼ 1 h were undergoing necrosis
rather than apoptosis. On the other hand, samples treated
with 10 and 20 ng/mL did not exhibit an obviously higher
percentage of TBE-positive than the control, indicating that
the chemical stimuli induced very mild necrosis, even no
necrosis, in these samples. After 24-h TNF-a treatment,
the death percentage of cells obviously increased and
expressed a monotonically increasing relation with the
TNF-a concentration. The control and 10 ng/mL samples
showed only very little increment in cell death; meanwhile
the death percentages of samples at the concentration of
20 ng/mL and above significantly increased from their
amounts at t ¼ 1 h. These profiles of death percentage
were similar to those of cell-substrate distance, indicating
the coherence of these two methods.
Apoptosis-dominant cardiomyocyte death
Because the cardiomyocyte sample treated with 20 ng/mL
TNF-a exhibited no obvious cell death at both t ¼ 0.5 h
and t ¼ 1 h but significant death percentage at t ¼ 24 h
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FIGURE 6 (a) Real-time recording
of cardiomyocyte adhesion in terms of
equivalent cell-substrate distance (solid
line) and absolute cell-substrate
distance (scattered dots with line). The
treatment was carried out on the cardio-
myocytes with 20 ng/mL TNF-a. (b)
Percentages of increase in equivalent
distance of TNF-a-treated and control
samples at t ¼ 24 h. (c) Phase-contrast
image of the TNF-a-treated sample.
(d) Corresponding fluorescent image
of the DAPI-stained TNF-a-treated
sample. (e) Corresponding fluorescent
image of the TUNEL-stained TNF-
a-treated sample. (f) Percentage of
TUNEL-positive cardiomyocytes
TNF-a-treated and control samples at
t ¼ 24 h (p < 0.01).
1990 Qiu et al.(Fig. 5 c), it was possible that apoptosis was at least involved.
According to published reports (27–30), TNF-a induces
caspase-involved apoptotic signaling pathways in cardio-
myocytes as an extracellular messenger protein. The activa-
tion of the caspase family will cause the detachment of
cardiomyocytes from the ECM or neighbor cells by cleaving
some essential proteins including focal adhesion kinase.
Because the activation of the caspase family occurs soon
after the binding of TNF-a to TNF receptors, the cell detach-
ment is expected to be seen not long after the treatment. The
2-day recording of cell-substrate distance was plotted in
Fig. 6 a, where the solid lines were the alteration of equiva-
lent cell-substrate distance. The addition of TNF-a induced
a rapid increase in equivalent cell-substrate distance after
a lag phase of ~2 h, which might be caused by the time
needed to activate the caspase family (26). The increasing
rate of equivalent distance slowly speeded up in the first
day and gently slowed down in ~2 days. The total increasing
amplitude of the treated sample was 61.8 nm, whereas that of
the control sample was 3.2 nm. We also compared the equiv-
alent cell-substrate distance with the absolute distance calcu-
lated via advanced ECIS. Besides the initial absolute
distance, the values at t¼ 24 h and t¼ 48 h were also plotted
in Fig. 6 a as scattered dots. The results showed the good
coherence of equivalent and absolute cell-substrate distance.
In short, TNF-a induced a significant increase in equivalent
cell-substrate distance (Fig. 6 b), which was caused by weak-
ening cell adhesion to ECM of the treated cardiomyocytes.
To determine whether apoptosis occurred to the cardio-
myocytes treated with 20 ng/mL TNF-a, the TUNEL tests
were carried out for the calibration of apoptosis. Fig. 6, c–e,
showed the corresponding phase contrast, DAPI-staining
fluorescent, and TUNEL-staining fluorescent images of
a TNF-a-treated cardiomyocytes (at t ¼ 24 h) in which
DNA fragmentation was indicated. The results of three inde-
pendent experiments were plotted in Fig. 6 f. After 24-h
Biophysical Journal 96(5) 1985–1991treatment with 20 ng/mL TNF-a, cardiomyocytes with
TUNEL positive were significantly increased (i.e., 21.1 5
5.5% versus 5.9 5 2.5% in time control, p < 0.01), indi-
cating that the degree of cardiomyocyte apoptosis was
prompted by TNF-a treatment. As shown in the TBE tests,
the death percentage was 17.35 1.2% at the same moment.
The apoptotic percentage was close to the total death
percentage, indicating that apoptosis was the major death
mechanism in the 20 ng/mL sample. The cell detachment
monitored in our assay reflected the dynamic process of
apoptotic cell death, which was presented in a unique
adhesion profile. Generally speaking, the adhesion profile
gathered with our methodology is a very direct and visual
indicator of cell morphology, which can enrich the technical
approaches to reveal cell responses.
CONCLUSION
In this work, a new impedance-based bioelectric assay was
developed for real-time monitoring of ongoing cardiomyo-
cyte death induced by TNF-a. The profile of cardiomyocyte
adhesion to ECM in terms of equivalent cell-substrate
distance could be obtained via the combination of EIS and
electric cell-substrate impedance sensing. The dynamic
process of cell detachment obtained with our assay was
proved to be related to cell death, which suggested the possi-
bility of predicting the consequent bioprocess. It was also
demonstrated that our assay could also achieve early detec-
tion of cell death earlier than Trypan blue tests. This novel
assay has the potential to become a valuable high-throughput
experimental approach to the research of cardiomyocytes.
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